Washington DC: Now you may soon find relief from migraine headaches as a new class of drugs is in the works to cure the pain.
The medications work to inhibit release of CGRP that is found to be elevated during migraine headache attacks and returns to normal when headaches are resolved, ExamHealth reported.
They would prevent migraine headaches before they start.
Professor Thomas Ward at Dartmouth in New Hampshire excitedly explained that it would be highly effective for people who have not had effective treatment.
Researchers say medications that block CGRP entirely could have a negative impact on the body's organs. The new class of drugs use monoclonal antibodies to target CGRP release that causes blood vessels to dilate and become inflamed.
Alder Pharmaceuticals, Amgen, Eli Lilly and Company, and Teva Pharmaceuticals are in the process of testing the drugs that could bring relief for a substantial number of migraine headache sufferers with minimal side effects. An injection could be taken once a month to stop headaches from developing.
It should be noted that the findings are preliminary.
